Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 2 |
2017 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent.
Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01947-16. doi: 10.1128/AAC.01947-16. Print 2017 Jan.
Antimicrob Agents Chemother. 2016.
PMID: 27821451
Free PMC article.
Clinical Trial.
X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action.
Parsonage D, Sheng F, Hirata K, Debnath A, McKerrow JH, Reed SL, Abagyan R, Poole LB, Podust LM.
Parsonage D, et al.
J Struct Biol. 2016 May;194(2):180-90. doi: 10.1016/j.jsb.2016.02.015. Epub 2016 Feb 12.
J Struct Biol. 2016.
PMID: 26876147
Free PMC article.
Item in Clipboard
New drug target in protozoan parasites: the role of thioredoxin reductase.
Andrade RM, Reed SL.
Andrade RM, et al.
Front Microbiol. 2015 Sep 30;6:975. doi: 10.3389/fmicb.2015.00975. eCollection 2015.
Front Microbiol. 2015.
PMID: 26483758
Free PMC article.
Review.
Item in Clipboard
Cite
Cite